Abstract:Type I interferons (IFNs) play essential roles in establishing and modulating host defense against microbial infection via induction of IFN-stimulated genes (ISGs) through Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling pathway. However, dysregulation of IFNs production and function could also mediate immune pathogenesis such as inflammatory autoimmune diseases and infectious diseases via aberrantly activating inflammatory responses or improperly suppressing microbial controls. Thus, IFN responses need to be tightly regulated to achieve protective immunity against microbial infection while avoiding harmful toxicity caused by improper or prolonged IFN signaling. Multiple levels of cellular and molecular events act in a cooperated manner to regulate IFN responses, in especial, post-translational modification (PTMs) of signaling molecules and epigenetic modification of gene expression programs are two important mechanisms for regulation of IFN signaling and thus critical for orchestrating IFN-mediated host immune response to the complex pathogenic or environmental stimuli. Conventional PTMs such as phosphorylation and polyubiquitylation, as well as numerous other PTMs including acetylation, ISGylation, SUMOylation and methylation have been shown to potently modulate type I IFN signaling transduction via targeting distinct signaling steps or components. Moreover, epigenetic mechanisms, such as histone modification, DNA methylation, non-coding RNAs play critical roles in regulating chromatin structure and function, leading to flexible and dynamic gene expression patterns downstream type I IFN signaling. Herein, we summarize the recent advances in the PTMs and epigenetic mechanisms in regulation of type I IFN signaling and responses. The involvement of dysregulated IFN signaling in inflammatory and autoimmune diseases are also discussed.

Type 1 Interferons Induce Changes in Core Metabolism That Are Critical for Immune Function

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Type I Interferons and Il-12: Convergence and Cross Regulation among Mediators of Cellular Immunity.

Metabolic regulation of type I interferon production

Type I Interferon Responses Drive Intrahepatic T Cells to Promote Metabolic Syndrome

Interferon α and β induce differential transcriptional and functional metabolic phenotypes in human macrophages and blunt glycolysis in response to antigenic stimuli

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during infection

Type I interferon governs immunometabolic checkpoints that coordinate inflammation during Staphylococcal infection

Type I interferons in infectious disease

Pathogen Recognition Receptor Signaling Accelerates Phosphorylation-Dependent Degradation of IFNAR1.

Fueling Autoimmunity: Type I Interferon in Autoimmune Diseases.

Interferon Gamma Induces Reversible Metabolic Reprogramming of M1 Macrophages to Sustain Cell Viability and Pro-Inflammatory Activity

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Type I interferon promotes the fate of Toll-like receptor 9–stimulated follicular B cells to plasma cell differentiation

Type-1 interferon induced cross-regulation of IL-10 function: a novel mechanism in type 1 diabetes development

Longitudinal system-based analysis of transcriptional responses to type I interferons

Metabolic Deficiencies Underlie Plasmacytoid Dendritic Cell Exhaustion After Viral Infection

Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy

Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality.

Type I IFNs facilitate innate immune control of the opportunistic bacteria Burkholderia cenocepacia in the macrophage cytosol